|
ZNF585B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12399999996349E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51130000003441E-06 |
| Normal-vs-Stage2 |
4.445200E-04 |
| Normal-vs-Stage3 |
1.061180E-03 |
| Normal-vs-Stage4 |
3.90040000000091E-05 |
| Stage1-vs-Stage2 |
9.089400E-01 |
| Stage1-vs-Stage3 |
8.403000E-01 |
| Stage1-vs-Stage4 |
2.164800E-01 |
| Stage2-vs-Stage3 |
9.560200E-01 |
| Stage2-vs-Stage4 |
2.447000E-01 |
| Stage3-vs-Stage4 |
3.318800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02670000001748E-06 |
| Normal-vs-AfricanAmerican |
2.356400E-04 |
| Normal-vs-Asian |
2.605800E-04 |
| Caucasian-vs-AfricanAmerican |
6.879400E-01 |
| Caucasian-vs-Asian |
3.105800E-01 |
| AfricanAmerican-vs-Asian |
1.890580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.4042000003095E-07 |
| Normal-vs-Female |
7.420000E-03 |
| Male-vs-Female |
4.818000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.602500E-04 |
| Normal-vs-Extreme_Weight |
6.987000000791E-08 |
| Normal-vs-Obese |
1.219900E-03 |
| Normal-vs-Extreme_Obese |
2.637100E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.008600E-01 |
| Normal_Weight-vs-Obese |
3.921800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.949600E-01 |
| Extreme_Weight-vs-Obese |
2.925600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.017200E-01 |
| Obese-vs-Extreme_Obese |
2.131800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.159600E-02 |
| Normal-vs-Age(41-60Yrs) |
4.047100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.06090000007164E-07 |
| Normal-vs-Age(81-100Yrs) |
1.53989999995829E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.235200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.658600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.281360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.297900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.406500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.856370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.1716000000025E-05 |
| Normal-VS-Type2 PRCC |
7.61440000052183E-07 |
| Normal-VS-KIRP CIMP |
1.248610E-01 |
| Normal-VS-Unclassified PRCC |
1.775780E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.758400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.227800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.905200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.468000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.428300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.824400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.06230000246543E-08 |
| Normal-vs-N1 |
1.261750E-02 |
| Normal-vs-N2 |
2.38790000000044E-05 |
| N0-vs-N1 |
3.629800E-01 |
| N0-vs-N2 |
5.212100E-02 |
| N1-vs-N2 |
1.191580E-01 |
|
|
